Someone tried. How much does it cost and how to get it News January 2020. Results of the open clinical trial conducted at the Medea Scientific Institute in Coniliano, in cooperation with the treatments of Frattagen, Department of Biomedicine and Prevention from the University of Rome “Tor Vergata” and Harvard Medical School, Boston, assessing the safety and effectiveness of gamma interferon (Imukin) in a small group of FA patients, indicates that the drug is generally well tolerated and that it can completely stop the development of the disease during treatment. Data were published in movement disorders. http://www.fratagene.com/index.php?id=9 @
Friedreich’s Ataxia News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.